Progression-Free Survival but Not Overall Survival Is Superior in Relapsed/Refractory Large B-Cell Lymphomas Treated with Axicabtagene Ciloleucel Compared to Tisagenlecleucel: Results of the CART-SIE Real Life Italian Study

Introduction The CART-SIE is a national prospective/retrospective observational study aimed at collecting the real-life data of all consecutive lymphoma patients treated with CAR-T cells in the Italian centers. Given the recognized efficacy of axicabtagene ciloleucel (axi-cel) and tisagenlecleucel (...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Blood 2023-11, Vol.142 (Supplement 1), p.2118-2118
Hauptverfasser:	Chiappella, Annalisa, Dodero, Anna, Casadei, Beatrice, De Philippis, Chiara, Ljevar, Silva, Galli, Eugenio, Di Rocco, Alice, Carrabba, Matteo Giovanni, Tisi, Maria Chiara, Musso, Maurizio, Cutini, Ilaria, Barbui, Anna Maria, Farina, Mirko, Martino, Massimo, Guidetti, Anna, Botto, Barbara, Grillo, Giovanni, Olivieri, Jacopo, Pennisi, Martina, Krampera, Mauro, Ladetto, Marco, Massaia, Massimo, Arcaini, Luca, Cavallo, Federica, Miceli, Rosalba, Martelli, Maurizio, Chiusolo, Patrizia, Bramanti, Stefania, Zinzani, Pier Luigi, Corradini, Paolo
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!